Client & Alumni News

OraSure receives $1.5M Ebola Test Order from CDC

OraSure Technologies Inc., the Bethlehem-based company that earlier this year developed a test for Ebola, will sell $1.5 million of its new product to the Centers for Disease Control and Prevention. The OraQuick Ebola Rapid Antigen Test uses the same technology OraSure deployed for creating its rapid HIV and HCV tests. Read more: